Retour
26
42
31
Fourchette du Jour
23,00 €
23,00 €
Fourchette 52 Semaines
20,60 €
37,36 €
Volume
7
Moyenne 50J / 200J
25,46 €
/
28,72 €
Clôture Précédente
23,00 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 3,6 | 0,2 |
| P/B | 0,8 | 3,0 |
| ROE % | 24,5 | 3,6 |
| Net Margin % | 17,0 | 3,8 |
| Rev Growth 5Y % | 20,3 | 9,9 |
| D/E | 0,4 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
11,92 €
11,49 € – 12,36 €
|
1,78B | 1 |
| FY2027 |
9,82 €
9,46 € – 10,18 €
|
1,59B | 1 |
| FY2026 |
7,85 €
7,56 € – 8,14 €
|
1,42B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-12 | 1,56 € | 0,22 € | -86,1% |
| 2025-08-08 | 0,12 € | 0,09 € | -19,5% |
| 2025-05-09 | 0,11 € | 0,17 € | +45,7% |
| 2025-02-21 | 0,12 € | 0,16 € | +32,6% |
| 2024-11-08 | 0,06 € | 0,13 € | +100,3% |
| 2024-08-16 | 0,07 € | 0,17 € | +140,5% |
| 2024-05-17 | 0,07 € | 0,10 € | +39,1% |
| 2024-02-23 | 0,07 € | 0,09 € | +26,3% |
Dividend History
2 yr streakYield
0,01%
Payout Ratio
0,45%
Growth (3Y)
N/A
Growth (5Y)
N/A
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| May 11, 2026 | May 15, 2026 | 0,43 € | 1,86% |
| May 23, 2025 | May 30, 2025 | 0,31 € | 0,98% |
| May 23, 2024 | May 29, 2024 | 0,19 € | 1,40% |
| May 18, 2016 | May 24, 2016 | 0,03 € | 0,21% |
| May 26, 2011 | Jun 03, 2011 | 0,08 € | 3,60% |
| May 26, 2010 | Jun 02, 2010 | 0,06 € | 2,86% |
| May 23, 2008 | May 30, 2008 | 0,08 € | 1,28% |
Points Clés
Revenue grew 20,31% annually over 5 years — strong growth
ROE of 24,47% indicates high profitability
Net margin of 16,95% shows strong profitability
Debt/Equity of 0,40 — conservative balance sheet
Generating 158,90M in free cash flow
P/E of 3,61 — trading at a low valuation
Croissance
Revenue Growth (5Y)
20,31%
Revenue (1Y)12,77%
Earnings (1Y)11,93%
FCF Growth (3Y)-19,73%
Qualité
Return on Equity
24,47%
ROIC15,88%
Net Margin16,95%
Op. Margin21,74%
Sécurité
Debt / Equity
0,40
Current Ratio1,70
Interest Coverage0,00
Valorisation
P/E Ratio
3,61
Forward P/E2,93
P/B Ratio0,83
EV/EBITDA2,77
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 12,77% | Revenue Growth (3Y) | 14,68% |
| Earnings Growth (1Y) | 11,93% | Earnings Growth (3Y) | 67,11% |
| Revenue Growth (5Y) | 20,31% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 1,34B | Net Income (TTM) | 227,80M |
| ROE | 24,47% | ROA | 11,44% |
| Gross Margin | 92,42% | Operating Margin | 21,74% |
| Net Margin | 16,95% | Free Cash Flow (TTM) | 158,90M |
| ROIC | 15,88% | FCF Growth (3Y) | -19,73% |
| Safety | |||
| Debt / Equity | 0,40 | Current Ratio | 1,70 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,45% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | 2 yrs | ||
| Valuation | |||
| P/E Ratio | 3,61 | Forward P/E | 2,93 |
| P/B Ratio | 0,83 | P/S Ratio | 0,61 |
| PEG Ratio | 2,76 | Forward PEG | N/A |
| EV/EBITDA | 2,77 | Fwd EV/EBITDA | 1,58 |
| Forward P/S | 0,58 | Fwd Earnings Yield | 34,13% |
| FCF Yield | 19,33% | ||
| Market Cap | 822,17M | Enterprise Value | 809,67M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,34B | 1,19B | 1,02B | 843,65M | 641,67M |
| Net Income | 227,80M | 203,51M | 81,57M | 23,78M | -47,32M |
| EPS (Diluted) | 6,65 | 5,94 | 2,38 | 0,69 | -1,38 |
| Gross Profit | 1,24B | 1,09B | 915,58M | 748,66M | 591,28M |
| Operating Income | 292,30M | 260,49M | 114,88M | 42,74M | -52,64M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,99B | 2,09B | 1,95B | 1,88B | 1,74B |
| Total Liabilities | 1,01B | 1,21B | 1,22B | 1,22B | 1,12B |
| Shareholders' Equity | 985,30M | 876,71M | 735,23M | 657,16M | 628,31M |
| Total Debt | 394,80M | 471,93M | 529,36M | 555,39M | 561,40M |
| Cash & Equivalents | 407,30M | 462,74M | 343,68M | 160,27M | 102,54M |
| Current Assets | 970,70M | 984,75M | 802,45M | 627,92M | 516,37M |
| Current Liabilities | 569,90M | 703,82M | 675,05M | 614,10M | 490,08M |
Scores de Stratégies
This stock passed the criteria for 3 strategies
Score = fit strength (0–100)
Rank = position among all matches
#680 of 826
#240 of 619
#137 of 203
Activité Récente
Sorti
Contrarian Investing (David Dreman)
Mar 26, 2026
Sorti
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entré
Contrarian Investing (David Dreman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026
Entré
Value Investing (Warren Buffett)
Mar 24, 2026